Non–Small Cell Lung Cancer (NSCLC) with Actionable Mutations : Episode 5

NSCLC Treatment: MET Exon 14 Skipping Mutations and RET Rearrangements

July 18, 2024

Opinion

Video

Balazs Halmos, MD, and the Oncology Brothers discuss therapeutic practices for patients with NSCLC, highlighting how MET exon 14 skipping mutations and RET rearrangements inform treatment decisions.

EP: 1.Treatment Algorithm for NSCLC with Common Sensitizing EGFR Mutations

EP: 2.Approach to Treating Patients with NSCLC with Uncommon EGFR Mutations

EP: 3.Treatment Approach for NSCLC with ALK Mutations

EP: 4.Therapeutic Options for NSCLC with Rare Mutations

Now Viewing

EP: 5.NSCLC Treatment: MET Exon 14 Skipping Mutations and RET Rearrangements

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!